Claudia R. Higgins brings more than two decades of distinguished service as an antitrust litigator with the Federal Trade Commission (FTC) to represent Fortune 500 companies in significant antitrust matters, particularly high-profile mergers, acquisitions, and joint ventures. She practices before the FTC, the US Department of Justice (DOJ), state attorneys general, and coordinates matters before international competition agencies. Her experience in antitrust matters spans a diverse set of industries, including pharmaceutical products, medical devices, consumer goods, defense and aerospace, natural resources, technology, and trade associations.
During her practice on behalf of the FTC, Ms. Higgins served as lead counsel in charge of some of the FTC's most noteworthy merger transactions, particularly those establishing innovation theory in the context of pharmaceutical mergers, and she also led trial teams in several of the agency's successful federal court injunction matters that blocked pending transactions. At the FTC, Ms. Higgins last held the title of Assistant Director for Regional Litigation with responsibility for the Commission's regional office antitrust efforts throughout the US. The agency recognized her outstanding accomplishments on numerous occasions, most notably honoring her with its Distinguished Service Award and the prestigious Paul Rand Dixon Award recognizing her leadership roles in merger enforcement.
Previously, Ms. Higgins served on the staff of the US Senate Committee on Governmental Affairs (now the Committee on Homeland Security and Governmental Affairs), where she worked on legislation related to Privacy and Regulatory Reform under Chairman Abraham Ribicoff (D-CT).
Ms. Higgins is a frequent author and speaker on antitrust and regulatory topics, and participates regularly in conferences, programs, and panels on issues of merger enforcement and trade regulation. Internationally, she has served as an instructor on behalf of the Organisation for Economic Co-Operation and Development in Paris and the US Agency for International Development, and has advised competition authorities in Romania, Latvia, Korea, Japan, Brazil, and numerous other countries. She has coordinated many investigations with the EU and its member nations.
Ms. Higgins attended American University Washington College of Law, where she was a member of the American University Law Review.
While with the FTC, Ms. Higgins appeared as lead counsel for consent decrees involving many of today's most prominent research-based pharmaceutical companies, the investigations for which invariably involved analysis of the patent rights of parties to the transaction, as well as complaints and information provided by competitors of the parties. Select FTC cases include:
- Ciba Geigy and Sandoz (now named Novartis)
- Glaxo and Wellcome (now part of GlaxoSmithKline)
- Upjohn and Pharmacia (now merged with Pfizer)
- American Home Products and American Cyanamid (now named Wyeth and merged with Pfizer)
- Hoechst and Rhone Poulenc; Hoechst and Marian Merrell Dow; Merieux and Connaught; Hoechst and BoehringerMannheim (now part of Sanofi)
- Merck and Medco (Medco has since left Merck and merged with Express Scripts)
- Rite Aid's attempted transaction with Revco
- FTC v. Harbour Group (US District Court, D.D.C. 1990)
- FTC v. McCormick Spice Co. (US District Court, D.D.C. 1988)
- In Re Kellogg, et al. (FTC Docket No. 8883)
- JD, American University Washington College of Law, 1977
- BA, University of Oklahoma, 1974
- District of Columbia
Assistant Director for Regional Litigation, Federal Trade Commission
Antitrust Litigator, Federal Trade Commission
- Past Vice-Chair, Exemptions and Immunities Committee, American Bar Association (2007-2008)
- Past Vice-Chair, Books and Treatises Committee, American Bar Association (2006-2007)
- Past Member, Antitrust Section Steering Committee, Antitrust and Consumer Law Section, District of Columbia Bar (2003-2007)
- Member, Advisory Board, Loyola Antitrust Institute United States Council for International Business (Competition Committee)